Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy.
Zou J, Kongtim P, Srour SA, Greenbaum U, Schetelig J, Heidenreich F, Baldauf H, Moore B, Saengboon S, Carmazzi Y, Rondon G, Ma Q, Rezvani K, Shpall EJ, Champlin RE, Ciurea SO, Cao K. Zou J, et al. Among authors: baldauf h. Front Immunol. 2022 Oct 13;13:1033871. doi: 10.3389/fimmu.2022.1033871. eCollection 2022. Front Immunol. 2022. PMID: 36311784 Free PMC article.
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Middeke JM, Kollinger F, Baldauf H, Stölzel F, Wermke M, von Bonin M, Sockel K, Link CS, Teipel R, Röllig C, Thiede C, Platzbecker U, Ehninger G, Bornhäuser M, Schetelig J. Middeke JM, et al. Among authors: baldauf h. Biol Blood Marrow Transplant. 2018 Sep;24(9):1947-1951. doi: 10.1016/j.bbmt.2018.05.021. Epub 2018 May 21. Biol Blood Marrow Transplant. 2018. PMID: 29793046 Free article.
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails.
Schetelig J, Baldauf H, Heidenreich F, Massalski C, Frank S, Sauter J, Stelljes M, Ayuk FA, Bethge WA, Bug G, Klein S, Wendler S, Lange V, de Wreede LC, Fürst D, Kobbe G, Ottinger HD, Beelen DW, Mytilineos J, Fleischhauer K, Schmidt AH, Bornhäuser M. Schetelig J, et al. Among authors: baldauf h. Blood. 2020 Apr 16;135(16):1386-1395. doi: 10.1182/blood.2019002887. Blood. 2020. PMID: 31932846 Free PMC article.
Blood group A epitopes do not facilitate entry of SARS-CoV-2.
Schetelig J, Baldauf H, Wendler S, Heidenreich F, Real R, Kolditz M, Rosner A, Dalpke A, de With K, Lange V, Markert J, Barth R, Bunzel C, Endert D, Hofmann JA, Sauter J, Bernas SN, Schmidt AH. Schetelig J, et al. Among authors: baldauf h. J Intern Med. 2021 Jul;290(1):223-226. doi: 10.1111/joim.13256. Epub 2021 Feb 25. J Intern Med. 2021. PMID: 33501658 Free PMC article. No abstract available.
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I, Robin M. Schetelig J, et al. Among authors: baldauf h. Front Immunol. 2021 Jan 19;11:584520. doi: 10.3389/fimmu.2020.584520. eCollection 2020. Front Immunol. 2021. PMID: 33542712 Free PMC article.
CCR5Δ32 mutations do not determine COVID-19 disease course.
Bernas SN, Baldauf H, Wendler S, Heidenreich F, Lange V, Hofmann JA, Sauter J, Schmidt AH, Schetelig J. Bernas SN, et al. Among authors: baldauf h. Int J Infect Dis. 2021 Apr;105:653-655. doi: 10.1016/j.ijid.2021.02.108. Epub 2021 Mar 2. Int J Infect Dis. 2021. PMID: 33667698 Free PMC article.
Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity.
Schetelig J, Heidenreich F, Baldauf H, Trost S, Falk B, Hoßbach C, Real R, Roers A, Lindemann D, Dalpke A, Kolditz M, de With K, Bornhäuser M, Bonifacio EE, Rücker-Braun E, Lange V, Markert J, Barth R, Hofmann JA, Sauter J, Bernas SN, Schmidt AH. Schetelig J, et al. Among authors: baldauf h. Front Immunol. 2021 Jul 26;12:698193. doi: 10.3389/fimmu.2021.698193. eCollection 2021. Front Immunol. 2021. PMID: 34381451 Free PMC article.
Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I, Robin M. Schetelig J, et al. Among authors: baldauf h. Front Immunol. 2021 Dec 21;12:813838. doi: 10.3389/fimmu.2021.813838. eCollection 2021. Front Immunol. 2021. PMID: 34992613 Free PMC article.
Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation.
Sarraf AA, Schetelig J, Baldauf H, Stölzel F, Middeke JM, Sockel K, Teipel R, Brückner S, Berning M, Zeissig S, Babatz J, Baretton GB, Hampe J, Bornhäuser M, Aust D, Schmelz R. Sarraf AA, et al. Among authors: baldauf h. Exp Hematol. 2022 Apr;108:36-45. doi: 10.1016/j.exphem.2022.01.005. Epub 2022 Jan 13. Exp Hematol. 2022. PMID: 35033627 Free article.
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.
Sockel K, Stölzel F, Hönl F, Baldauf H, Röllig C, Wermke M, von Bonin M, Teipel R, Link-Rachner C, Brandt K, Kroschinsky F, Hänel M, Morgner A, Klesse C, Ehninger G, Platzbecker U, Bornhäuser M, Schetelig J, Middeke JM. Sockel K, et al. Among authors: baldauf h. Cancer Manag Res. 2022 Feb 15;14:547-559. doi: 10.2147/CMAR.S339846. eCollection 2022. Cancer Manag Res. 2022. PMID: 35210852 Free PMC article.
70 results